Evidence map›Paper›PMID 25171330›Full record

ArticleThe ISME journal2015

Species specificity of symbiosis and secondary metabolism in ascidians.

Ma Diarey B Tianero, Jason C Kwan, Thomas P Wyche, Angela P Presson, Michael Koch, Louis R Barrows, Tim S Bugni, Eric W Schmidt

Abstract read
In one paragraph

Article in The ISME journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. An organic extract from ascidianFrontiers in chemistry · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ma Diarey B TianeroDepartment of Medicinal Chemistry, L.S. Skaggs Pharmacy Institute, University of Utah, Salt Lake City, UT, USA.
Jason C Kwan1] Department of Medicinal Chemistry, L.S. Skaggs Pharmacy Institute, University of Utah, Salt Lake City, UT, USA [2] School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA.
Thomas P WycheSchool of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA.
Angela P PressonStudy Design and Biostatistics Center, Division of Epidemiology, University of Utah, Salt Lake City, UT, USA.
Michael KochDepartment of Pharmacology and Toxicology, L.S. Skaggs Pharmacy Institute, University of Utah, Salt Lake City, UT, USA.
Louis R BarrowsDepartment of Pharmacology and Toxicology, L.S. Skaggs Pharmacy Institute, University of Utah, Salt Lake City, UT, USA.
Tim S BugniSchool of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA.
Eric W SchmidtDepartment of Medicinal Chemistry, L.S. Skaggs Pharmacy Institute, University of Utah, Salt Lake City, UT, USA.

Funding

University of Utah Center for Clinical and Translational ScienceUL1TR001067 · NCATS · UNIVERSITY OF UTAH · PI DERE, WILLARD H., HESS, RACHEL · 2013 to 2017
$19.8M
UNIVERSITY OF UTAH CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE-UL1: BPCAUL1RR025764 · NCRR · UNIVERSITY OF UTAH · PI MCCLAIN, DONALD A. · 2008 to 2011
$19.4M
University of Utah Center for Clinical and Translational Science-UL1UL1TR000105 · NCATS · UNIVERSITY OF UTAH · PI MCCLAIN, DONALD A. · 2012 to 2013
$5.1M
Marine symbiotic interactions for discovery of bioactive compoundsR01GM107557 · NIGMS · UNIVERSITY OF UTAH · PI SCHMIDT, ERIC W · 2013 to 2016
$1.2M
Rapid Screening and Dereplication of Marine Symbiotic Natural ProductsR01GM092009 · NIGMS · UNIVERSITY OF UTAH · PI SCHMIDT, ERIC W · 2010 to 2012
$1.1M
NCATS NIH HHS 8UL1TR000105NCATS NIH HHS UL1 TR000105NCATS NIH HHS UL1 TR001067NCRR NIH HHS UL1 RR025764NIGMS NIH HHS GM092009NIGMS NIH HHS GM107557NIGMS NIH HHS R01 GM092009NIGMS NIH HHS R01 GM107557
6 · The paper itself

Abstract

Ascidians contain abundant, diverse secondary metabolites, which are thought to serve a defensive role and which have been applied to drug discovery. It is known that bacteria in symbiosis with ascidians produce several of these metabolites, but very little is known about factors governing these 'chemical symbioses'. To examine this phenomenon across a wide geographical and species scale, we performed bacterial and chemical analyses of 32 different ascidians, mostly from the didemnid family from Florida, Southern California and a broad expanse of the tropical Pacific Ocean. Bacterial diversity analysis showed that ascidian microbiomes are highly diverse, and this diversity does not correlate with geographical location or latitude. Within a subset of species, ascidian microbiomes are also stable over time (R=-0.037, P-value=0.499). Ascidian microbiomes and metabolomes contain species-specific and location-specific components. Location-specific bacteria are found in low abundance in the ascidians and mostly represent strains that are widespread. Location-specific metabolites consist largely of lipids, which may reflect differences in water temperature. By contrast, species-specific bacteria are mostly abundant sequenced components of the microbiomes and include secondary metabolite producers as major components. Species-specific chemicals are dominated by secondary metabolites. Together with previous analyses that focused on single ascidian species or symbiont type, these results reveal fundamental properties of secondary metabolic symbiosis. Different ascidian species have established associations with many different bacterial symbionts, including those known to produce toxic chemicals. This implies a strong selection for this property and the independent origin of secondary metabolite-based associations in different ascidian species. The analysis here streamlines the connection of secondary metabolite to producing bacterium, enabling further biological and biotechnological studies.

Indexed as

Secondary MetabolismSymbiosisAnimalsBacteriaBacterial Physiological PhenomenaBiodiversityCaliforniaFloridaPacific OceanSpecies SpecificityUrochordata

Identifiers

PMID25171330
PMCPMC4331574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.